Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07719894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Study acronym: Cilo-Asa
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Patients with type 2 diabetes and cardiovascular risk factors are at increased risk of cardiovascular events. Therefore, a multi-center prospective randomized study will be conducted to compare the efficacy and safety of cilostazol and aspirin for the prevention of major adverse cardiac and cerebrovascular events (MACCE) in high-risk patients with type 2 diabetes.
Trial Details
NCT Number NCT07719894
Lead Sponsor Seoul National University Bundang Hospital
Conditions
(from sponsor)		 Type 2 Diabetes Mellitus (T2DM), Atherosclerosis
Related terms Atherosclerosis, Diabetes Mellitus, Type 2
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov